Back to User profile » Dr Na Wu
Papers published by Dr Na Wu:
Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
Song L, Zhang ZZ, Hu RG, Cheng J, Li L, Fan QY, Wu N, Gan J, Zhou MZ, Liu ZG
Drug Design, Development and Therapy 2016, 10:547-555
Published Date: 3 February 2016
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
Song L, Yang X, Ma Y, Wu N, Liu Z
Drug Design, Development and Therapy 2014, 8:2173-2180
Published Date: 4 November 2014
Effect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson's disease
Wu N, Yang X, Song L, Wei J, Liu Z
Drug Design, Development and Therapy 2013, 7:1481-1489
Published Date: 10 December 2013
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
Yang X, Chen Y, Hong X, Wu N, Song L,Yuan W, Liu Z
Drug Design, Development and Therapy 2012, 6:341-347
Published Date: 20 November 2012